Free Trial

Achieve Life Sciences (ACHV) Insider Trading & Ownership

Achieve Life Sciences logo
$3.69 -0.13 (-3.40%)
(As of 12/20/2024 05:51 PM ET)

Achieve Life Sciences (NASDAQ:ACHV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.00%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$27,500.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get ACHV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Achieve Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACHV Insider Buying and Selling by Quarter

Achieve Life Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/30/2023John BencichCEOBuy5,000$5.50$27,500.00  
(Data available from 1/1/2013 forward)

ACHV Insider Trading Activity - Frequently Asked Questions

The list of insiders at Achieve Life Sciences includes John Bencich. Learn more on insiders at ACHV.

2.00% of Achieve Life Sciences stock is owned by insiders. Learn more on ACHV's insider holdings.

The following insider purchased ACHV shares in the last 24 months: John Bencich ($27,500.00).

Insiders have purchased a total of 5,000 ACHV shares in the last 24 months for a total of $27,500.00 bought.

Achieve Life Sciences Key Executives

  • Dr. Richard A. B. Stewart (Age 65)
    Executive Chairman
    Compensation: $663.75k
  • Mr. John A. Bencich M.B.A. (Age 47)
    CEO & Director
    Compensation: $781.75k
  • Dr. Cindy Jacobs M.D. (Age 66)
    Ph.D., President, Chief Medical Officer & Director
    Compensation: $652.74k
  • Mr. Jerry Wan (Age 42)
    Principal Accounting Officer
  • Dr. Anthony Clarke Ph.D. (Age 68)
    Chief Scientific Officer
    Compensation: $546k
  • Ms. Jaime Xinos
    Executive Vice President of Commercial


This page (NASDAQ:ACHV) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners